Isothrive

Biotechnology · Microbiome

Overview

Treating Chronic Disease Caused by Microbiome Dysbiosis. We develop novel, proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis. Correcting dysbiosis is a potentially disease modifying MoA in numerous disease states of high unmet need.

Funding and backers

Total raised
$17.4M
3 rounds on record
Latest round
$8.1M
Venture round · Oct 2025 · 12 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 10, 2025 Raised a round Venture round $8.1M · SEC Form D Jan 22, 2021 Raised a round Venture round $5.2M · SEC Form D Oct 31, 2019 Raised a round Venture round $4M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 $8.1M — SEC Form D
Venture round Jan 2021 $5.2M — SEC Form D
Venture round Oct 2019 $4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity ISOThrive Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Jack OswaldExecutive Officer, DirectorSEC Form D
Alyn OswaldExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
mbiomicsVenture round · 6 mo ago · Founded 2020
Decoding the microbiome. We design and develop complex Live Biotherapeutic Products (LBPs) to change the treatment paradigm of severe and…
P.HappiVenture round · 4 mo ago
P.Happi® is a daily serum that supports the intimate microbiome by protecting from bad bacteria and supporting the natural flora. The first…
Discover your unique microbiome with InnerBuddies' Microbiome Test. Improve your gut health with personalised advice tailored to your…
AMILISeries A $10.5M · 4 yr ago · Founded 2019
AMILI runs Southeast Asia's first gut microbiome bank and offers microbiome testing and therapeutic research. Its data addresses the…
OutpostPre-Seed $3.5M · 8 mo ago · Founded 2019 · 11-50 employees
Outpost builds AI models of the human microbiome so drug, food, and ingredient R&D teams can predict microbiome interactions and flag risks…
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial…

Financials

Total raised
$17.4M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $8.1M Details
Venture - Series Unknown 2021 $5.2M Details
Venture - Series Unknown 2019 $4M Details

People

Jack Oswald
Executive Officer, Director
Alyn Oswald
Executive Officer, Director
James Farrell
Director
Fadi Karam
Director
Mike Walther
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Healdsburg United States
HQ
Reach Out:
50-200 est. staff
Healdsburg, CA 95448
company site